|
Nemours Center for Childhood Cancer Research Receives Over $1 Million in Grants for Cancer Research in 2008 (PRWeb)
The research team at the Nemours Center for Childhood Cancer Research (NCCCR), a newly established division of Nemours Biomedical Research headquartered at the Alfred I. duPont Hospital for Children in Wilmington, DE, has secured $1,020,000 in external funding for awards starting in 2008 and 2009. (PRWeb Jan 8, 2009) Read the full story at ...
us.rd.yahoo.com
Nemours Center for Childhood Cancer Research Receives Over $1 Million in Grants for Cancer Research in 2008 (PRWeb via Yahoo! News)
The research team at the Nemours Center for Childhood Cancer Research (NCCCR), a newly established division of Nemours Biomedical Research headquartered at the Alfred I. duPont Hospital for Children in Wilmington, DE, has secured $1,020,000 in external funding for awards starting in 2008 and 2009.
us.rd.yahoo.com
Study shows grapeseed extract kills cancer cells (China Daily)
recently reported on some amazing new research published in the Clinical Cancer Research journal. Researchers found that leukemia cancer cells could be killed off when exposed to grapeseed extract. The cells quickly died from apoptosis, or cell suicide.
us.rd.yahoo.com
American Association for Cancer Research Hosts Science of Health Care Disparities Meeting (Newswise)
Although racial and ethnic differences in treatment and outcomes among cancer patients are well known, little is understood about the underlying causes and what can be done to solve a seemingly intractable problem. The American Association for Cancer Research is hosting a collaboration of scientists who are working to understand what can be done to address this situation.
us.rd.yahoo.com
Juvaris BioTherapeutics Announces Positive Data from Clinical Trial of JVRS-100 Adjuvanted Flu Vaccine (Centre Daily Times)
Juvaris BioTherapeutics, Inc., a biotechnology company developing adjuvanted vaccines and immunotherapeutics for infectious diseases and cancer, today announced positive results from a Phase 1 clinical trial of its lead compound, JVRS-100, as an adjuvant for influenza vaccines.
us.rd.yahoo.com
Orphan Drug Designation In Gastric Cancer For Tesetaxel, A Leading Oral Taxane In Clinical Development (Medical News Today)
Genta Incorporated (OTCBB: GNTA) announced that the Company has received notice from the U.S. Food and Drug Administration (FDA) that tesetaxel, the latest addition to Genta's oncology product portfolio, has been granted designation as an "Orphan Drug" for treatment of patients with advanced gastric cancer.
us.rd.yahoo.com
Hormone Therapy Associated With Reduced Colorectal Cancer Risk (Medical News Today)
The combination of estrogen plus progestin, which women stopped taking in droves following the news that it may increase their risk of breast cancer, may decrease their risk of colorectal cancer, according to a report published in the January issue of Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer Research.
us.rd.yahoo.com
Hormone therapy associated with reduced colorectal cancer risk (EurekAlert!)
( American Association for Cancer Research ) The combination of estrogen plus progestin, which women stopped taking in droves following the news that it may increase their risk of breast cancer, may decrease their risk of colorectal cancer, according to a report published in the January issue of Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer ...
us.rd.yahoo.com
Hauptman closer to breast cancer cure (BizJournals)
A Buffalo researcher at Hauptman-Woodward Medical Research Institute has moved a step closer to a cure, and possibly the prevention, of the most common type of breast cancer.
us.rd.yahoo.com
Menopause treatment reduces risk of bowel cancer (Daily Telegraph)
Women who take hormone replacement therapy for symptoms of the menopause may reduce their risk of bowel cancer by up to 45 per cent research has found.
us.rd.yahoo.com
|
